The review outlines the foundational pharmacological and device therapies for managing congestive heart failure and preventing sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Supports CHF guideline-directed care now; confirms foundational benefits while leaving open optimization in contemporary cohorts.
Somberg et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: